Bacillus Coagulans Market

Bacillus Coagulans Market Study by Animal-based and Plant-based for Food & Beverages, Pharmaceuticals, and Nutraceuticals from 2023 to 2033

Analysis of Bacillus Coagulans Market Insights Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Bacillus Coagulans Market Outlook (2023 to 2033)

The global bacillus coagulans market is valued at US$ 100 million in 2023 and is expected to reach US$ 210 million by 2033-end. Global demand for bacillus coagulans is predicted to increase at a high-value CAGR of 7.7% from 2023 to 2033.

Bacillus coagulans is widely used in the cosmetics and personal care industry because of its enormous benefits for treating skin conditions such as acne and anti-aging disorders. Prominent companies in the industry are creating and launching new formulations and cosmetic goods, which is boosting overall market growth.

Bacillus coagulans is a type of good bacteria used similarly to other probiotics. It helps to aid digestive disorders and general digestion problems. It also supports in prevention of respiratory infections and boosts the immune system.

The bacteria has been incorporated into probiotics that are designed to particularly target the human digestive system because of its capacity to withstand extremely acidic environments. It helps to relieve stomach aches, gas, constipation, abdominal pain, and irritable bowel syndrome.

  • Improved immunity, the avoidance of respiratory conditions, and anti-carcinogenic qualities are some additional advantageous characteristics of bacillus coagulans.

Bacillus coagulans produce lactic acid, however, unlike lactic acid bacteria, bacillus coagulans form a reproductive structure known as spores. These spores are essential factors in bacillus coagulans and differentiate them from other lactic acid bacteria.

The potential of the bacterium for a variety of tasks connected to shielding humans against diseases has increased interest in the use of bacillus coagulants. It supports immune system development, guard against tooth decay, and are especially helpful in preventing coronary heart problems. Because it is stable in its heat-resistant spore form, this has been a major benefit to food manufacturers.

Growing consumer interest in the probiotic food business is a significant trend supporting market growth. The future of the bacillus coagulans market has been improved by the advancements in genome sequencing, which have provided significant insights into the characterization of the bacterium.

New developments in the probiotics industry are anticipated to fuel market expansion. Significant drivers of market growth are rising rates of non-communicable diseases and obesity. Probiotics, vitamins, and functional foods are becoming more popular as a result of increased consumer awareness regarding wellness and disease in emerging countries.

An increase in spending by key market players on the R&D of new probiotics has resulted in the release of new products, opening up several market opportunities for producers. Companies' efforts to deliver probiotics in enticing formulations such as bars, yogurt, and chewing tablets are anticipated to draw consumers to probiotic and prebiotic products, fueling market expansion.

Report Attributes


Bacillus Coagulans Market Size (2023)

US$ 100 Million

Projected Market Value (2033)

US$ 210 Million

Global Market Growth Rate (2023 to 2033)

7.7% CAGR

Market Share of North America


Key Companies Profiled

  • Ganeden
  • UAS Laboratories
  • Sabinsa Corporation
  • Syngen Biotech
  • Microbax
  • Nebraska Culture
  • Mitsubishi Chemical Foods Corporation
  • Sanzyme Biologics
  • Aumgene Bioscience

Don't Need a Global Report?

save 40%! on Country & Region specific reports

What is Paving the Way for Producers of Bacillus Coagulans?

“Increasing Prevalence of Chronic Digestive Diseases”

Changing lifestyles and diets are leading to a rise in chronic digestive diseases across the globe. Bacillus coagulans help to promote digestive health and encourage a healthy immune system.

  • The positive effect of bacillus coagulans in serious digestive disorders is resulting in increased consumption of fortified foods and beverages.

Several food and beverage companies are adding bacillus coagulans to their products, targeting many people suffering from digestive disorders.

Bacillus coagulans emerged as a trending probiotic that helps to maintain gastrointestinal health. The use of bacillus coagulans is rapidly increasing in weight management as it has been scientifically shown to burn fat and boost metabolism.

“Rapid Use of Bacillus Coagulans in Dairy-free Food Products”

New dairy-free probiotic foods are introduced to the market, demonstrating the importance of health and wellness in new product development tactics.

  • Demand for plant-based probiotics is increasing due to the rising vegan and vegetarian population, a rise in milk protein allergies, and an increase in lactose intolerance.

Demand for heat-treated food products is rising as a result of the high stability of bacillus coagulans during processing and heating. Due to their low cost and availability as an alternative to other dangerous chemical sources, products of bacillus coagulans are utilized in the food business and are becoming more popular.

“Growing Demand for Infant Nutrition Products”

Infants and young children are experiencing several issues with their digestive systems. Infectious gastrointestinal disorders in children are becoming more widespread worldwide and are quite common in infants younger than 15 months. So, by incorporating bacillus coagulans into newborn nutrition products, it is possible to enhance gut health overall, which will support increased immune response and bowel motions.

People are paying closer attention to the food they consume regularly. Leading market players have been forced to broaden their product portfolios with a wide range of actual fruit-based probiotics as a result of the growing demand for probiotic products created with only natural and pure ingredients. Fermented foods such as kimchi, sauerkraut, and yogurt are natural sources of bacillus coagulans.

Supplements for bacillus coagulans are accessible as capsules and pellets. Supplements may be sold when they are in their latent, spore-like state before becoming active in the intestines.

How is Industry Growth Being Restrained to Some Extent?

“Strict Government Guidelines for Probiotic Product Approval”

Strict government guidelines for probiotic product approval may impede market expansion. Although bacillus coagulans' side effects are very minimal, dosage mistakes might cause bloating and intestinal gas. Because it is not a component of the digestive system naturally, there is ongoing discussion over its potential risks and negative effects. There have been several bacillus coagulans strains discovered that may not be suitable for use as probiotics.

Compared to other probiotics, bacillus coagulans may provide many advantages, however, research on these probiotics is yet limited. The possibility that bacillus coagulans spores will escape the digestive system and enter other organs is another concern.

As a result, it is not advised for those who use a catheter or those with immunocompromised conditions as it could result in bacterial infection. Moreover, bacillus coagulans interact with several medications in a way that could lead to more side effects and impair immune response.

Bacillus coagulans market growth forecast by Fact.MR

Which Region Holds a Leading Position in the Bacillus Coagulans Market?

“Rising Awareness of Probiotics' Nutritional Properties in North America”

  • North America accounts for 50% share of the global market.

Increasing hectic lifestyles of working people, changes in their eating habits, and huge demand for nutritional food products are driving market growth in the region. The demand for bacillus coagulans is boosted by growing awareness of probiotics' nutritional and health-promoting properties among consumers.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Country-wise Insights

What is the Market Outlook for Bacillus Coagulans in the United States?

“Increased Usage in Rising Number of Medical and Healthcare Facilities”

Bacillus coagulans is an essential component of livestock management, as a result of the significant export of livestock, the market in the United States is expected to rise over the forecast period. An increase in medical and healthcare facilities and a rise in the incidence of chronic diseases are boosting market expansion.

Why is Germany Exhibiting High Demand for Bacillus Coagulans?

“Growing Prevalence of Digestive Cancer in the Country”

Market growth in Germany is attributed to the growing prevalence of digestive cancer, the high demand for animal feed probiotics, and the strong emphasis on enhancing digestive health. Increasing investments in the commercial production of functional food products with good stability features and a rise in the local supply of nutraceuticals are stimulating market revenue.

What is Making Japan Stand Out in the Asia Pacific Market?

“Huge Demand for Nutritional Supplements across Japan”

An increase in obese people, increasing healthcare expenditures, growing geriatric population are the elements encouraging industry expansion. Huge demand for nutritional supplements and the growing usage of healthcare items are projected to aid the expansion of the bacillus coagulans market.

Category-wise Insights

Which Application of Bacillus Coagulans Accounts for a Dominant Market Share?

“Bacillus Coagulans Widely Used in Cosmetics and Personal Care Products for Treating Skin Conditions and Acne”

Based on application, the market is divided into food & beverages, pharmaceuticals, cosmetics and personal care, nutraceuticals, and animal feed.

  • Demand for bacillus coagulans is rising in the cosmetics and personal care industry due to its significant advantages in treating skin conditions and acne.

Moreover, cosmeceutical components are being developed by cosmetics manufacturers for usage in a variety of cosmetic goods such as powders, gels, face scrubs, lotions, and creams. The use of bacillus coagulans is growing in popularity for controlling and treating eczema and atopic dermatitis symptoms. Its inclusion in cosmetic items such as anti-acne face wash and moisturizing lotion is on the rise. Bacillus coagulans is a biologically active skin protector that is widely utilized in cosmetics and personal care products.

Competitive Landscape

Major market participants are engaged in maintaining product standards and investing in R&D activities to launch new products. Key market players are focusing on expanding their manufacturing facilities following safety regulations, quality control, collaborations, and supply chain management. Leading companies are also concentrating on pricing trends and entering into strategic partnerships with regional distributors and suppliers.

For instance :

  • Ganeden, a US-based probiotic ingredient manufacturer, was recently acquired by Kerry Group. As a result of the acquisition, Ganeden technologies will be extended into wider applications across Kerry’s developed and developing markets.
  • Sabinsa Corp. opened its new office in Toronto, expanding its presence in Canada. The new office will facilitate Canadian importers to comply with Canadian regulations.
  • Mitsubishi Chemical and JD.Com entered into a partnership to launch a large “plant factory” in China based on hydroponic technology. The factory produces red and green lettuce, spinach, cabbage, coriander, and other vegetables. The factory can produce more vegetables compared to the conventional system.
  • UAS Laboratories announced the acquisition of Nebraska Cultures Inc. Through the acquisition, UAS has exclusivity over Lactobacillus Acidophilus DDS-1 and ProDURA brand.
  • Throne entered into a joint strategic investment with Kirin Holdings Company and Mitsui & Co. Ltd. This strategic investment will help Throne to expand its personalized health products and technology platform and grow its businesses in Asia.

Key Segments of Bacillus Coagulans Industry Research

  • By Product Type :

    • Animal-based
    • Plant-based
  • By Form :

    • Capsules
    • Pellets
  • By Application :

    • Food & Beverages
      • Gummies
      • Bakery & Confectionery
      • Dairy Products
      • Beverages
      • Baby Foods
      • Meat Products
      • Finished products (Granola, Protein Bars, and Breakfast Cereals)
    • Pharmaceuticals
      • Dietary Supplements
      • Veterinary Purposes
    • Cosmetics and Personal Care
      • Skin Care
      • Hair Care
    • Nutraceuticals
    • Animal Feed
  • By Region :

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

- FAQs -

What is the market value for bacillus coagulans in 2023?

Worldwide demand for bacillus coagulans is valued at US$ 100 million in 2023.

What size is the bacillus coagulans market expected to reach by 2033?

The global bacillus coagulans market is estimated to reach US$ 210 million by 2033.

Who are the key providers of bacillus coagulans?

Ganeden, UAS Laboratories, and Sabinsa Corporation are leading producers of bacillus coagulans.

What is the predicted growth rate of the market for bacillus coagulans?

The bacillus coagulans market is forecasted to rise at a CAGR of 7.7% through 2033.

Which is the leading regional market for bacillus coagulans?

North America accounts for 50% share of the global market for bacillus coagulans.

Bacillus Coagulans Market

Schedule a Call